Title : Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression.

Pub. Date : 2020 Nov

PMID : 32934734






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression. Emodin ATP binding cassette subfamily B member 1 Homo sapiens
2 In addition, emodin treatment reduced resistance to gemcitabine, which was characterized by the downregulation of P-glycoprotein, MRP1 and MRP5 expression in the group receiving combination treatment. Emodin ATP binding cassette subfamily B member 1 Homo sapiens
3 The level of P-glycoprotein was also decreased in the group treated with gemcitabine+emodin compared with the single treatment groups. Emodin ATP binding cassette subfamily B member 1 Homo sapiens
4 Taken together, these results demonstrated that emodin enhanced gemcitabine efficacy in tumor treatment and alleviated gemcitabine resistance in PANC-1 cell xenografts in mice via suppressing MDR1/P-glycoprotein and MRP expression. Emodin ATP binding cassette subfamily B member 1 Homo sapiens